Cited by 68Epilepsy research and treatmentIon channel regulation and functionPharmacological Effects and Toxicity Studies

Insights into pathophysiology and therapy from a mouse model of Dravet syndrome

Open access
Oakley, John C., Kalume, Franck, Catterall, William A.·2011·Epilepsia

Abstract

Summary: Mutations in voltage‐gated sodium channels are associated with epilepsy syndromes with a wide range of severity. Complete loss of function in the Na v 1.1 channel encoded by the SCN1A gene is associated with severe myoclonic epilepsy in infancy (SMEI), a devastating infantile‐onset epilepsy with ataxia, cognitive dysfunction, and febrile and afebrile seizures resistant to current medications. Genetic mouse models of SMEI have been created that strikingly recapitulate the SMEI phenotype including age and temperature dependence of seizures and ataxia. Loss‐of‐function in Na v 1.1 channels results in severely impaired sodium current and action potential firing in hippocampal γ‐aminobutyric acid (GABA)ergic interneurons without detectable changes in excitatory pyramidal neurons. The resulting imbalance between excitation and inhibition likely contributes to hyperexcitability and seizures. Reduced sodium current and action potential firing in cerebellar Purkinje neurons likely contributes to comorbid ataxia. A mechanistic understanding of hyperexcitability, seizures, and comorbidities such as ataxia has led to novel strategies for treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1528-1167.2011.03004.x

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • More than 300 mutations in SCN1A exons account for about 70% of Dravet syndrome cases; most are truncations or deletions disrupting voltage sensing or ion conduction, and the remaining 30% likely act through effects on SCN1A expression.

    “Identification of >300 mutations in SCN1A exons accounts for ∼70% of DS cases; and most mutations are truncations or deletions that disrupt voltage sensing or ion conduction, with the remaining 30% likely acting through their impact on SCN1A expression (Oakley et al., 2011).”
  • Decreased inhibitory firing leads to dysregulation of inhibition, the likely cause of seizures in Dravet syndrome patients.

    “In turn, decreased inhibitory firing leads to dysregulation of inhibition, the likely cause of seizures in DS patients (Oakley et al., 2011).”
  • SCN1A loss-of-function impairs sodium currents and spiking in hippocampal GABAergic interneurons without a detectable effect on excitatory pyramidal neurons.

    “SCN1A loss-of-function impairs sodium currents and spiking in hippocampal GABAergic interneurons, without a detectable effect on excitatory pyramidal neurons.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Oakley, J. C., Kalume, F., & Catterall, W. A.
Affiliations
University of Washington (US)
Corresponding author
Catterall, William A.
Venue
Epilepsia
Publisher
Wiley
Published
2011-04
Volume
52
Issue
s2
Pages
59-61
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W1597950071
Cited by
68
References
15
Citations by year
2025: 3 · 2024: 1 · 2023: 8 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 7 · 2018: 3 · 2017: 2 · 2016: 7 · 2015: 6 · 2014: 8 · 2013: 6 · 2012: 2
FWCI
4.18
Type
journal article
Language
en
Open access
Locations
  • Epilepsia (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Neurological Disorders and Stroke (K01NS062862, R01NS025704)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Keywords
Dravet syndrome, SCN1A, Nav1.1 sodium channel, mouse model, GABAergic interneurons, Purkinje cells, ataxia, excitatory-inhibitory imbalance, epilepsy treatment
MeSH terms
Animals, Ataxia, Disease Models, Animal, Epilepsies, Myoclonic, Humans, Nerve Tissue Proteins, Syndrome, Sodium Channels, Mice, NAV1.1 Voltage-Gated Sodium Channel

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review